CTRI/2019/11/022099尚未招募4 期
Effect of Tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease - a 6 month follow up study.
DrAnjana Asokan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •eGFR >25ml/min/1.73m2
- •Total kidney volume >750 ml
排除标准
- •eGFR <25 ml/min/1.73m2
- •Total kidney volume <750ml
- •Atypical cases of polycystic kidney disease
- •Hepatic diseases (other than hepatic cysts)
- •Heart failure
- •Subjects unable to take plenty of fluids
- •Pregnant and lactating patients
- •Patient requiring intervention or surgery.
- •Patients not tolerating tolvaptan.
- •Need for diuretic use
- •Patients with advanced diabetes mellitus
研究者
相似试验
进行中（未招募）
1 期
Same as aboveMedDRA version: 20.0Level: LLTClassification code 10036045Term: Polycystic kidneySystem Organ Class: 100000004850Autosomal Dominant Polycystic Kidney DIseaseEUCTR2017-004115-39-DKordsjællands Hospital, Department of Cardiology, Nephrology and Endocrinology90
已完成
不适用
The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failurecongestive heart failureJPRN-UMIN000014134ishiarai Heart Center Hospital80
Unknown
4 期
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic KidneyNCT03596957Lisbet Brandi90
进行中（未招募）
1 期
The effects of tolvaptan on renal handeling of water and salt, hormones in the blood and the circulation, during blocking of the nitric oxide (NO) system in healthy subjects. A dose-response study.HyponatremiaSIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)MedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 100000004860EUCTR2013-003800-38-DKDepartment of Medical Research22
招募中
不适用
Study of the renal protective effect of tolvaptan as a replacement of loop diuretics for the treatment of ascites in cirrhotic patients with renal dysfunctioliver cirrhosisJPRN-UMIN000044693Tohoku Medical and Pharmaceutical University15